Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry R Kranzler

Showing results (1-10 of 568) with videos related to

Pageof 57
Sort By:
Addiction (Abingdon, England)|July 22, 2014
Commentary on Garbutt et al. (2014): Can we predict who benefits from naltrexone in the treatment of alcohol dependence?Henry R Kranzler
The American Journal of Psychiatry|August 1, 2023
Overview of Alcohol Use DisorderHenry R Kranzler
Alcoholism, Clinical and Experimental Research|July 25, 2015
Endorsement of the CONSORT Principles in Reporting Alcohol Clinical Trials in ACERHenry R Kranzler
Alcoholism, Clinical and Experimental Research|February 27, 2016
New Initiatives for Alcoholism: Clinical and Experimental ResearchHenry R Kranzler
Alcoholism, Clinical and Experimental Research|May 17, 2021
Policy changes for Alcoholism: Clinical and Experimental Research (ACER)Henry R Kranzler
Drugs|September 19, 2006
Extended-release intramuscular naltrexone: a viewpoint by Henry R KranzlerHenry R Kranzler
Alcohol, Clinical & Experimental Research|December 15, 2022
Announcing a name change for ACERHenry R Kranzler
Alcohol, Clinical & Experimental Research|May 8, 2024
Welcoming ACER's new EditorHenry R Kranzler
JAMA|May 4, 2006
Evidence-based treatments for alcohol dependence: new results and new questionsHenry R Kranzler
Alcoholism, Clinical and Experimental Research|March 30, 2022
Is it time to rethink low-risk drinking guidelines?Henry R Kranzler
Pageof 57

Showing results (1-10 of 568) with videos related to

Sort By:
Pageof 57
Addiction (Abingdon, England)|July 22, 2014
Commentary on Garbutt et al. (2014): Can we predict who benefits from naltrexone in the treatment of alcohol dependence?Henry R Kranzler
The American Journal of Psychiatry|August 1, 2023
Overview of Alcohol Use DisorderHenry R Kranzler
Alcoholism, Clinical and Experimental Research|July 25, 2015
Endorsement of the CONSORT Principles in Reporting Alcohol Clinical Trials in ACERHenry R Kranzler
Alcoholism, Clinical and Experimental Research|February 27, 2016
New Initiatives for Alcoholism: Clinical and Experimental ResearchHenry R Kranzler
Alcoholism, Clinical and Experimental Research|May 17, 2021
Policy changes for Alcoholism: Clinical and Experimental Research (ACER)Henry R Kranzler
Drugs|September 19, 2006
Extended-release intramuscular naltrexone: a viewpoint by Henry R KranzlerHenry R Kranzler
Alcohol, Clinical & Experimental Research|December 15, 2022
Announcing a name change for ACERHenry R Kranzler
Alcohol, Clinical & Experimental Research|May 8, 2024
Welcoming ACER's new EditorHenry R Kranzler
JAMA|May 4, 2006
Evidence-based treatments for alcohol dependence: new results and new questionsHenry R Kranzler
Alcoholism, Clinical and Experimental Research|March 30, 2022
Is it time to rethink low-risk drinking guidelines?Henry R Kranzler
Pageof 57